The second stool panel identified was one consisting of RARB2, p16, MGMT, and APC. This panel detected CRC with 75% sensitivity, adenomas with 60% sensitivity, and the specificity was 100% [49]. The gene discussed is CDKN2A; the disease is colorectal carcinoma.